Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR), a biopharmaceutical company with a market capitalization of $2.68 billion ...

HC Wainwright reaffirmed their buy rating on shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR – Free Report) in a research note issued to investors on Thursday morning,Benzinga reports.

On the other hand, Arrowhead Pharmaceuticals has entered into a significant strategic partnership with Sarepta Therapeutics, involving a $500 million upfront payment and a $325 million equity ...

Arrowhead Pharmaceuticals Inc (ARWR) stock saw a decline, ending the day at $20.76 which represents a decrease of $-0.77 or -3.58% from the prior close of $21.53. The stock opened at $21.23 and ...

Read Our Latest Report on ARWR Arrowhead Pharmaceuticals Trading Down 3.6 % ARWR opened at $20.76 on Friday. The firm has a market cap of $2.58 billion, a P/E ratio of -4.14 and a beta of 0.97 ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR), a biopharmaceutical company with a market capitalization of $2.68 billion specializing in RNA interference (RNAi) technology, is on the cusp of a ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Abbott Laboratories (ABT – Research Report), ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Taylor Swift walked the Arrowhead Stadium tunnel for the final time of the 2024-2025 football season on Sunday. Videos showed the singer arriving about 90 minutes before kickoff. A golf cart drove ...

As Arrowhead Stadium was being built in the late 1960s and early 1970s, the sleek and revolutionary design stressing comfort, sightlines and acoustics was a futuristic endeavor. One that nicely ...